Evaluating the Impact of the RWHAP: From Cost-Effectiveness to Clinical Care

Presentation Event
2020 National Ryan White Conference on HIV Care & Treatment
Organization
HRSA HIV/AIDS Bureau
Presenter(s)
Pamela Klein, Robert Mills
Description

This workshop will present findings from three recently completed HRSA/HAB-sponsored studies that evaluated the impact of the RWHAP, specifically regarding its cost-effectiveness, models of clinical care, and factors associated with viral suppression.

Learning Objectives

  1. Describe the cost-effectiveness of the RWHAP.
  2. Describe the impact of different clinical care models on HIV clinical outcomes.
  3. Describe factors associated with RWHAP clients reaching and/or maintaining viral suppression.

Event Details

Event:
2020 National Ryan White Conference on HIV Care & Treatment
Track:
Data Utilization
Abstract:
15576

We'd like your feedback

Was this page helpful?
I found this page helpful because the content on the page:
Check all that apply
I did not find this page helpful because the content on the page:
Check all that apply
Please include an email address if you would like a response
Please include an email address if you would like a response
Did you use this approach in your work?
Not yet because
If no, why not?